American Century Companies’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
Other funds holding ORKA
FFM
RI
PBA
DTC
BG
American Century Companies's ORKA Position: Q2 2026 in Review
American Century Companies reduced its Oruka Therapeutics (ORKA) stake by 93% in Q2 2026, selling an estimated $4.63M and leaving 4,948 shares worth $471K. The position accounts for ﹤0.01% of the portfolio, ranked #2594.
American Century Companies first reported a position in ORKA in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.65M in Q1 2026. 237 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.
- American Century Companies held 4,948 shares of Oruka Therapeutics worth $471K as of Q2 2026.
- American Century Companies sold 69,438 Oruka Therapeutics shares in Q2 2026, an estimated $4.63M.
- Oruka Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2594 holding.
- American Century Companies first reported a position in Oruka Therapeutics in Q3 2025 and has held it in 4 quarters since.
- American Century Companies's Oruka Therapeutics position peaked at $3.65M in Q1 2026.
- 237 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.